Identification of candidates for coronary artery bypass grafting admitted with STEMI and Multivessel Disease

Ramón Rodríguez-Olivares1, José López-Menéndez2, Laura Varela Barca2

  • 1Department of Cardiology, Ramón y Cajal University Hospital, Madrid, Spain; Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Spain.

Insights

Optimal management for multivessel coronary artery disease (MVD) in ST-elevation myocardial infarction (STEMI) patients remains debated. A SYNTAX II PCI score over 40 indicates potential candidates for complete surgical revascularization (CSR) after initial culprit vessel treatment.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Management of multivessel coronary artery disease (MVD) in ST-elevation myocardial infarction (STEMI) is complex.
  • Coronary artery bypass grafting (CABG) is underutilized, even in suitable patients.
  • Provisional percutaneous coronary intervention (PCI) may enable complete surgical revascularization (CSR) in select MVD patients.

Purpose of the Study:

  • To identify patients with STEMI and MVD who are ideal candidates for CSR.
  • To evaluate predictors of adverse events in this patient cohort.
  • To inform optimal revascularization strategies for complex coronary artery disease.

Main Methods:

  • Retrospective analysis of STEMI patients from April 2014 to October 2016.
  • Inclusion criteria: TIMI flow <3 in culprit vessel, >70% stenosis in another major vessel/side branch.
  • Analysis of epidemiological data, surgical risk scores, SYNTAX, and SYNTAX II scores; post hoc heart team discussion.

Main Results:

  • Seventy-two patients (19.0%) met MVD criteria.
  • Mean SYNTAX score was 19±13; SYNTAX II recommended CABG in 16.7% of patients.
  • Heart team identified 29.2% as potential CSR candidates; SYNTAX II PCI >40 predicted 12-month events (OR 12.9).

Conclusions:

  • STEMI patients with MVD and SYNTAX II PCI >40 require heart team evaluation.
  • Consider CSR for these patients, particularly with right coronary artery culprit and complex left coronary disease.
  • Provisional revascularization of the culprit vessel followed by heart team discussion is recommended.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
504
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
292
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
404
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
709
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
387